Skip to main content
. 2021 Jul 30;100(30):e26701. doi: 10.1097/MD.0000000000026701

Table 4.

Comparison of the frequencies of the 10 most common problems endorsed.

Pre-treatment Post-treatment
Treatment (65) Control (65) Treatment (55) Control (53)
Variable No. (%) No. (%) χ2 No. (%) No. (%) χ2 P
Fears 48 (73.85) 46 (70.77) 0.154 30 (54.55) 40 (75.47) 5.183 .023
Sleep/insomnia 44 (67.69) 45 (69.30) 0.036 21 (38.18) 39 (73.58) 13.701 .000
Memory decline 35 (53.85) 33 (50.77) 0.123 29 (52.73) 28 (52.83) 0.000 .988
Nervous, anxiety 34 (52.31) 35 (53.85) 0.031 17 (30.91) 27 (50.94) 4.487 .034
Fatigue 46 (70.77) 41 (63.08) 0.869 39 (70.91) 42 (79.25) 1.000 .317
Pain 38 (58.46) 37 (56.92) 0.032 41 (74.55) 36 (67.92) 0.578 .447
Insurance/financial 39 (60.00) 41 (63.08) 0.130 42 (76.36) 38 (70.70) 0.306 .580
Loss of appetite 31 (47.69) 33 (50.77) 0.123 15 (27.27) 30 (56.60) 9.554 .002
Nausea/vomiting 29 (44.62) 26 (40.00) 0.284 28 (50.91) 25 (47.17) 0.151 .698
Tingling hands/feet 26 (40.00) 25 (38.46) 0.032 28 (50.91) 24 (45.28) 0.342 .559